S&P Global Ratings has upgraded the credit rating of Alvogen Pharma US Inc. to ’CCC+’ from ’SD’ (selective default) following the successful completion of a debt restructuring transaction. The ...
The UK targets 87% GHG reduction by 2040. Discover the CCC's balanced pathway and key strategies towards achieving net-zero ...
Q4 2024 Earnings Call Transcript February 25, 2025 CCC Intelligent Solutions Holdings Inc. reports earnings inline with expectations. Reported EPS is $0.1 EPS, expectations were $0.1. Operator: Good ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback